Raghu Rao - 27 Oct 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
27 Oct 2023
Transactions value $
$0
Form type
4
Filing time
27 Oct 2023, 20:00:10
Previous filing
22 Dec 2022
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase +15.6K +1315.24% 16.8K 27 Oct 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SONN Warrant to Purchase Common Stock Purchase +31.3K 31.3K 27 Oct 2023 Common Stock 31.3K $1.60 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person purchased 15,625 shares of common stock and 31,250 warrants to purchase 31,250 shares of common stock pursuant to an underwritten public offering by the Issuer at $1.60 per share and accompanying two warrants. The offering closed on October 27, 2023.
F2 Includes unvested RSUs.
F3 All amounts reflect the 1:22 reverse stock split effective as of August 31, 2023.